Navigation Links
FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): NAD Metabolism & Signaling.

In recent years, it has become increasingly clear that NAD and related metabolites are involved in a wide variety of critical biological processes and pathophysiology of various diseases, including type 2 diabetes and other metabolic complications. In the past decade, many unanticipated, exciting discoveries have been made in the field of NAD biology: new NAD-dependent reactions have been discovered (e.g. NAD-dependent protein deacylation by sirtuins), new enzymes and metabolites have been identified (e.g. nicotinamide phosphoribosyltransferase (NAMPT), nicotinamide riboside kinase (NRK), and O-acetyl-ADP-ribose), new NAD biosynthetic pathways have been revealed (e.g. a new pathway starting from nicotinamide riboside), and new intra- and extracellular NAD-dependent signaling pathways have been characterized (e.g. the NAADP signaling pathway, and NAD-induced cell death of immune cells).

These new discoveries have obviously fueled much more enthusiasm on NAD biology to the scientific community than ever, and classic paradigms, in which NAD/NADH and NADP/NADPH are considered just as co-enzymes, are now quickly being transformed into a novel, more comprehensive view of NAD biology. Indeed, reflecting this exciting trend, the number of publications on NAD biology has dramatically increased in these years. The newly developing areas of NAD biology require extensive, interdisciplinary interactions among scientists with diverse expertise including enzymology, structural biology, medicinal/biological chemistry, cell biology, physiology, genetics, many omics, and translational medicine. Therefore, it is essential to bring those scientists together to a comprehensive, interdisciplinarily organized meeting and fully discuss these cutting-edge fronts of NAD biology for better understanding of their pathophysiological significance. The 2013 FASEB SRC on "NAD Metabolism & Signaling", which started first in Carefree, AZ in 2009, will aim to cover all cutting-edge fronts of NAD biology and provide a great opportunity to nurture further synergism among attendees from many different fields and stimulate interdisciplinary collaborative efforts.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
2. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
3. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
4. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
5. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
6. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
7. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
8. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
9. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
10. FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
11. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... SOUTH SAN FRANCISCO, Calif. , April 19, ... VCYT ) today announced that it ... after close of market on Wednesday, May 3, 2017. ... call and webcast at 4:30 p.m. Eastern Time to discuss ... The live webcast and subsequent replay may ...
(Date:4/18/2017)... ... April 18, 2017 , ... METTLER TOLEDO Process ... concentration levels and vice-versa. , One of the key applications for the measurement ... control or monitoring. The principle of this analytical method is based on pure ...
(Date:4/18/2017)... ... April 18, 2017 , ... For a historic seventh consecutive ... the VaxCorps vaccine consortium, were named one of the top two Clinical Research Sites ... of this category; winning the award four times previously, and first runner up the ...
(Date:4/18/2017)... ... April 18, 2017 , ... Cancer ... Boguski has been appointed to the role of Chief Medical Officer (CMO) – ... , “Dr. Boguski is widely considered a visionary leader in precision medicine, and ...
Breaking Biology Technology: